Related Experiment Video
Updated: Aug 7, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
508
Pan-Cancer Analysis Reveals Functional Similarity of Three lncRNAs across Multiple Tumors
Abir Khazaal1,2, Seid Miad Zandavi1,3, Andrei Smolnikov1
1School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, NSW 2052, Australia.
International Journal of Molecular Sciences
|March 11, 2023
Summary
Long non-coding RNAs (lncRNAs) are key regulators in biological processes and cancer. This pan-cancer study identified seven lncRNAs common across eight cancer types, highlighting their role in tumor progression.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Long non-coding RNAs (lncRNAs) are critical regulators of biological processes.
- Dysregulated lncRNA expression is linked to various diseases, notably cancer, influencing initiation, progression, and metastasis.
- Understanding lncRNA functions in tumorigenesis is vital for developing novel cancer biomarkers and therapeutic strategies.
Purpose of the Study:
- To conduct a comprehensive pan-cancer analysis of lncRNAs.
- To identify differentially expressed lncRNAs between tumor and adjacent non-neoplastic tissues across eight cancer types.
- To investigate the functional implications of consistently dysregulated lncRNAs in cancer.
Main Methods:
- Utilized extensive cancer datasets encompassing genomic and transcriptomic alterations.
- Performed differential expression analysis of lncRNAs across eight cancer types.
- Conducted functional enrichment analyses to understand the biological processes associated with dysregulated lncRNAs.
Main Results:
- Identified seven lncRNAs that were consistently dysregulated across all eight cancer types analyzed.
- Focused on three specific lncRNAs exhibiting consistent dysregulation in tumors.
- Observed interactions of these three lncRNAs with numerous genes, enriching similar biological pathways involved in cancer progression and proliferation.
Conclusions:
- lncRNAs play a significant role in pan-cancer progression.
- Seven specific lncRNAs are potential pan-cancer biomarkers.
- The identified dysregulated lncRNAs are promising targets for future cancer therapies.
More Related Videos
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
02:38The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K